For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
State Directed Payments redistribute money across states and supercharged growth
Differences in states’ use of SDPs cause an interstate redistribution of taxes as well. Because states are setting different levels of SDPs, spending varies…
Blog
How State Directed Payments turned Medicaid into an interstate transfer scheme
Medicaid’s financing rules have long allowed states to expand spending while shifting much of the cost to federal taxpayers. One of the most important…
Blog
Medicaid financing gimmickry – before and after the One Big Beautiful Bill
Medicaid was created in 1965 as a joint federal-state health insurance program for low-income individuals which targeted families with dependent children, the elderly, and…
Search Posts
Blog
Free the Economy podcast: Alcohol labels and warnings with David Clement
In this week’s episode we cover housing abundance in California, the meaning of a market economy, union privileges for government…
News Release
Senate Big Beautiful Bill Contains Needed Medicaid Reforms
The Senate today voted 51 to 50 to pass the Reconciliation package known as the “One Big Beautiful Bill,” following House passage in…
News Release
Senate Parliamentarian Eliminates Medicaid Reform Provisions, Leaving Costs/Problems Intact
The Senate’s parliamentarian has determined that many of the Medicaid provisions in the One Big Beautiful Bill cannot be passed with simple majority vote…
Blog
FDA can’t stomach fluoride and doesn’t want you to, either
On May 13, the Food and Drug Administration (FDA) announced that it would begin a process intended to exclude ingestible prescription fluoride products…
Blog
Free the Economy podcast: Drug costs and benefits with Sally Pipes
In this week’s episode we cover reforms to the Endangered Species Act, attacks on US tech firms, nuclear power…
Blog
The MAHA Report is a missed opportunity
Less than six months into the new administration, the Department of Health and Human Services (HHS) has produced its Make Our Children Healthy…